Literature DB >> 2180651

Stromal cells in haemopoiesis.

T M Dexter1, L H Coutinho, E Spooncer, C M Heyworth, C P Daniel, R Schiro, J Chang, T D Allen.   

Abstract

Stromal cells of the bone marrow can provide the growth-promoting and differentiation-inducing molecules which are necessary for haemopoiesis. While the nature of these stimuli is largely unknown, the development of haemopoietic cells in association with stromal cells requires intimate cell contact. Molecules of the extracellular matrix, such as heparan sulphate, are able to bind growth factors and in this way the stromal cells may form microenvironmental niches which preferentially promote development of multipotent and committed cells along discrete lineages. Cells from some patients with acute and chronic myeloid and lymphoid leukaemias are defective in their ability to interact with stromal cells and consequently cannot survive in stromal cell-mediated long-term marrow cultures. We have exploited this phenomenon to obtain normal haemopoietic cells from patients with leukaemia, and to use these cells for successful autografting in patients with acute and chronic myeloid leukaemias.

Entities:  

Mesh:

Year:  1990        PMID: 2180651     DOI: 10.1002/9780470513880.ch6

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  13 in total

1.  Gangliosides of myelosupportive stroma cells are transferred to myeloid progenitors and are required for their survival and proliferation.

Authors:  Ana L Ziulkoski; Cláudia M B Andrade; Pilar M Crespo; Elisa Sisti; Vera M T Trindade; Jose L Daniotti; Fátima C R Guma; Radovan Borojevic
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

2.  Differentiation of the rat myelomonocytic leukemia cell line c-WRT-7 by in vitro culture with the rat bone marrow preadipocyte cell line REC A16.

Authors:  T Tanaka; S Okamura; S Yasumoto; N Takeichi; H Kobayashi; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Overcoming the barriers to umbilical cord blood transplantation.

Authors:  Susan Staba Kelly; Simrit Parmar; Marcos De Lima; Simon Robinson; Elizabeth Shpall
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

4.  Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis.

Authors:  Anupama Narla; Shilpee Dutt; J Randall McAuley; Fatima Al-Shahrour; Slater Hurst; Marie McConkey; Donna Neuberg; Benjamin L Ebert
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

5.  Haemopoietic regrowth after chemotherapy for acute leukaemia: an immunohistochemical study of bone marrow trephine biopsy specimens.

Authors:  B S Wilkins; A G Bostanci; M F Ryan; D B Jones
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

6.  Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53.

Authors:  R J Nibbs; K Itoh; W Ostertag; P R Harrison
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration.

Authors:  E I Korpelainen; J R Gamble; W B Smith; G J Goodall; S Qiyu; J M Woodcock; M Dottore; M A Vadas; A F Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

Review 8.  Ex vivo expansion of cord blood.

Authors:  S S Kelly; C B S Sola; M de Lima; E Shpall
Journal:  Bone Marrow Transplant       Date:  2009-10-05       Impact factor: 5.483

9.  Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood.

Authors:  G Pasternak; L Pasternak
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

10.  Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor.

Authors:  R S Taichman; S G Emerson
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.